Total Payments
$530.53
2024 Payments
$18.09
Companies
13
Transactions
18
Medicare Patients
26,707
Medicare Billing
$22.7M
Payment Breakdown by Category
Food & Beverage$312.26 (58.9%)
Education$184.57 (34.8%)
Gifts$33.70 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $312.26 | 10 | 58.9% |
| Education | $184.57 | 7 | 34.8% |
| Gift | $33.70 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sirtex Medical Inc | $122.98 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $98.95 | 1 | $0 (2020) |
| Elekta, Inc. | $91.36 | 1 | $0 (2019) |
| PFIZER INC. | $50.24 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $42.60 | 3 | $0 (2024) |
| Welch Allyn | $33.70 | 1 | $0 (2020) |
| Celgene Corporation | $18.58 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 1 | $0 (2020) |
| Karyopharm Therapeutics Inc. | $12.45 | 1 | $0 (2020) |
| Acrotech Biopharma LLC | $11.97 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.09 | 1 | Merck Sharp & Dohme LLC ($18.09) |
| 2023 | $13.86 | 1 | PFIZER INC. ($13.86) |
| 2021 | $23.89 | 2 | Acrotech Biopharma LLC ($11.97) |
| 2020 | $174.67 | 5 | Astellas Pharma US Inc ($98.95) |
| 2019 | $259.21 | 6 | Sirtex Medical Inc ($122.98) |
| 2018 | $11.41 | 1 | Novocure Inc. ($11.41) |
| 2017 | $29.40 | 2 | Celgene Corporation ($18.58) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2023 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/13/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Education | In-kind items and services | $12.45 | General |
| Category: Oncology | ||||||
| 08/17/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $98.95 | General |
| 08/17/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $17.33 | General |
| Category: Oncology | ||||||
| 05/06/2020 | Welch Allyn | None (Device) | Gift | In-kind items and services | $33.70 | General |
| Category: Not Applicable | ||||||
| 03/12/2020 | PFIZER INC. | RUXIENCE (Biological) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2019 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $122.98 | General |
| Category: Interventional Oncology | ||||||
| 07/12/2019 | PFIZER INC. | MYLOTARG (Biological), DAURISMO | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2019 | Elekta, Inc. | Versa HD (Device), Mosaiq, Esteya | Food and Beverage | Cash or cash equivalent | $91.36 | General |
| Category: ELEKTA LINEAR ACCELERATOR | ||||||
| 02/15/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Oncology | ||||||
| 02/13/2019 | PFIZER INC. | DAURISMO (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $11.41 | General |
| Category: Optune | ||||||
| 06/01/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Hematology / Oncology | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 114 | 6,604 | 449,020 | $17.5M | $6.3M |
| 2022 | 110 | 6,650 | 457,366 | $17.0M | $6.1M |
| 2021 | 118 | 7,172 | 418,126 | $16.9M | $6.1M |
| 2020 | 111 | 6,281 | 338,215 | $12.1M | $4.3M |
Total Patients
26,707
Total Services
1,662,727
Medicare Billing
$22.7M
Procedure Codes
453
All Medicare Procedures & Services
453 procedure records from CMS Medicare Utilization — Page 5 of 19
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 94 | 246 | $1,230 | $199.51 | 16.2% |
| 84100 | Phosphate level | Office | 2023 | 13 | 40 | $560.00 | $186.00 | 33.2% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 21 | 35 | $455.00 | $151.70 | 33.3% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2023 | 23 | 51 | $612.00 | $150.31 | 24.6% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2023 | 31 | 214 | $428.00 | $134.51 | 31.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 33 | 81 | $810.00 | $82.69 | 10.2% |
| 82565 | Blood creatinine level | Office | 2023 | 16 | 16 | $240.00 | $80.32 | 33.5% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 17 | 19 | $152.00 | $79.42 | 52.3% |
| 84155 | Total protein level, blood | Office | 2023 | 15 | 18 | $378.00 | $64.80 | 17.1% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2023 | 16 | 16 | $192.00 | $61.92 | 32.3% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 29 | 62 | $930.00 | $61.92 | 6.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 13 | 13 | $130.00 | $55.77 | 42.9% |
| J3480 | Injection, potassium chloride, per 2 meq | Office | 2023 | 29 | 475 | $950.00 | $41.29 | 4.3% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 24 | 240 | $4,080 | $18.37 | 0.5% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2022 | 54 | 34,003 | $3.2M | $1.4M | 43.2% |
| J9299 | Injection, nivolumab, 1 mg | Office | 2022 | 34 | 34,424 | $1.9M | $799,398 | 42.2% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2022 | 21 | 16,740 | $1.4M | $606,444 | 42.6% |
| J9022 | Injection, atezolizumab, 10 mg | Office | 2022 | 17 | 7,608 | $1.1M | $485,218 | 44.9% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2022 | 40 | 9,500 | $845,180 | $329,839 | 39.0% |
| J1930 | Injection, lanreotide, 1 mg | Office | 2022 | 14 | 6,240 | $761,280 | $320,742 | 42.1% |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | Office | 2022 | 17 | 5,240 | $681,200 | $259,822 | 38.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 58 | 14,220 | $597,240 | $242,329 | 40.6% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2022 | 63 | 1,596 | $509,124 | $196,124 | 38.5% |
| J9041 | Injection, bortezomib (velcade), 0.1 mg | Office | 2022 | 25 | 4,725 | $373,275 | $141,331 | 37.9% |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Office | 2022 | 14 | 12,300 | $307,500 | $134,945 | 43.9% |
About Dr. Richard Cherny, M.D
Dr. Richard Cherny, M.D is a Hematology & Oncology healthcare provider based in East Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659351484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Cherny, M.D has received a total of $530.53 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($312.26).
As a Medicare-enrolled provider, Cherny has provided services to 26,707 Medicare beneficiaries, totaling 1,662,727 services with total Medicare billing of $22.7M. Data is available for 4 years (2020–2023), covering 453 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location East Syracuse, NY
- Active Since 01/18/2006
- Last Updated 08/03/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659351484
Products in Payments
- SIR-Spheres Microspheres (Device) $122.98
- Versa HD (Device) $91.36
- None (Device) $33.70
- KEYTRUDA (Biological) $31.78
- Revlimid (Drug) $18.58
- OPDIVO (Biological) $17.33
- XTANDI (Drug) $13.86
- XPOVIO (Drug) $12.45
- MYLOTARG (Biological) $12.31
- RUXIENCE (Biological) $12.24
- BELEODAQ (Drug) $11.97
- DAURISMO (Drug) $11.83
- Oncology (Device) $11.41
- EMEND (Drug) $10.82
- Rubraca (Drug) $7.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in East Syracuse
Santosh Kumar, Md, MD
Hematology & Oncology — Payments: $31,857
Hematology & Oncology $31,857
Vinod Varki, M.d, M.D
Hematology & Oncology — Payments: $14,348
Hematology & Oncology $14,348
Dr. Tarek Sousou, Md, MD
Hematology & Oncology — Payments: $3,099
Hematology & Oncology $3,099
Santo Difino, M.d, M.D
Hematology & Oncology — Payments: $1,159
Hematology & Oncology $1,159
Benny Wong, M.d, M.D
Hematology & Oncology — Payments: $1,083
Hematology & Oncology $1,083
Aref Agheli, Md, MD
Hematology & Oncology — Payments: $666.07
Hematology & Oncology $666.07